Highlights IQ-AI Limited

Equities

Market Closed - London S.E. Other stock markets 09:05:01 28/06/2024 pm IST			5-day change	1st Jan Change
1.1 ^GBX	-4.35%		-8.33%	-76.60%

25/06	IQ-AI subsidiary opens expanded access programme	AN
14/06	IQ-AI Says Brain Cancer Drug Delays Disease Progression in Early-stage Study	MT

IQ-AI Says Brain Cancer Drug Delays Disease Progression in Early-stage Study	14/06	MT
IQ-AI team begins defining phase 2 protocol for oral gallium maltolate	14/06	AN
IQ-AI Ltd. Provides Update on Phase 1 Update	14/06	CI
Celadon ships to US; Oxford BioDynamics-Goodbody pact	24/05	AN
IQ-AI subsidiary gets second FDA rare paediatric disease designation	20/05	AN
Ingenta trades in line; Triple Point Social NAV up	17/05	AN
IQ-AI Unit Delivers Software to Insel Gruppe	17/05	MT
EARNINGS AND TRADING: Trident Royalties swings to profit	02/05	AN
IQ-AI Limited Provides Revenue Guidance for the Financial Year 2024	29/04	CI
IQ-AI Limited Reports Earnings Results for the Full Year Ended December 31, 2023	29/04	CI
IQ-AI shares sink on discounted placing fundraise	22/02	AN
IQ-AI Unit to Revise, Resubmit Pediatric Rare Disease Designation Application After US FDA Feedback	09/02	MT
IQ-AI subsidiary asked by FDA to resubmit and modify application	09/02	AN
IQ-AI Unit Secures Grant for Brain Tumor Pill Access Program	02/02	MT
IQ-AI celebrates USD100,000 grant for subsidiary	02/02	AN
IQ-AI falls after subsidiary notes launch of treatment access scheme	10/01	AN
IQ-AI's Imaging Biometrics Plans Expanded Access Program for Brain Tumor Treatment	10/01	MT
IQ-AI Applies for FDA Pediatric Rare Disease Designation	08/11	CI
IQ-AI Unit’s Study Validates IB Neuro Platform for Reduced Gadolinium Approach on 1.5T MR Scanners	08/23/08	MT
Mayo Clinic Reverts IQ-AI Shares as IB Trax Deal Closes	18/23/18	MT

No results for this search